Bonnie L. Hall, PhD
- Research Assistant Professor
Education & Training
- PhD in Molecular Biology, University of Pittsburgh, 2003
- BS in Biology, Pennsylvania State University, 1997
Research Interests
Publications
Jackson JW, Hall BL, Marzulli M, et al. 2021. Treatment of glioblastoma with current oHSV variants reveals differences in efficacy and immune cell recruitment. Mol Ther Oncolytics. 22: 444-453. doi:10.1016/j.omto.2021.07.009
Hall BL, Leronni D, Miyagawa Y, Goins WF, Glorioso JC, Cohen JB. 2020. Generation of an oncolytic herpes simplex viral vector completely retargeted to the GDNF receptor gfrα1 for specific infection of breast cancer cells. Int J Mol Sci. 21 (22). doi:10.3390/ijms21228815
Tuzmen C, Cairns TM, Atanasiu D, et al. 2020. Point Mutations in Retargeted gD Eliminate the Sensitivity of EGFR/EGFRvIII-Targeted HSV to Key Neutralizing Antibodies. Mol Ther Methods Clin Dev. 16: 145-154. doi:10.1016/j.omtm.2019.12.013
Miyagawa Y, Verlengia G, Reinhart B, et al.2017. Deletion of the Virion Host Shut-off Gene Enhances Neuronal-Selective Transgene Expression from an HSV Vector Lacking Functional IE Genes. Mol Ther Methods Clin Dev. 6: 79-90. doi:10.1016/j.omtm.2017.06.001
Reinhart B, Goins WF, Harel A, et al. 2016. An HSV-based library screen identifies PP1α as a negative TRPV1 regulator with analgesic activity in models of pain. Mol Ther Methods Clin Dev. 3: 16040. doi:10.1038/mtm.2016.40